Skip to main content
Log in

Regional Differences in Quinine Absorption from the Undisturbed Human Colon Assessed Using a Timed Release Delivery System

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. To investigate the regional absorption characteristics of the distal gut using two markers of permeability, quinine (a transcellular probe) and 51CrEDTA (a paracellular probe).

Methods. The permeability markers were delivered to the undisturbed gastrointestinal tract in 39 healthy volunteers using an oral timed-release delivery vehicle which allowed pulsed release within a particular site of the gut. Site of release was identified using gamma scintigraphy. Absorption of quinine and 5lCrEDTA was assessed by measuring the percent excretion in the urine using HPLC and gamma counting respectively. Serial plasma samples allowed time-concentration curves for quinine to be plotted.

Results. There was a significant trend for diminished absorption with more distal delivery of the transcellular probe, quinine, which was: 6.26 ± 0.87% (small intestine, n = 10); 4.65 ± 0.93% (ascending colon, n = 16); and 2.59 ± 0.52% (transverse colon, n = 10) of the ingested dose excreted respectively (p < 0.001). No such gradient was seen with the paracellular marker, 5lCrEDTA.

Conclusions. These results suggest that delayed release formuations should aim for release in the distal small bowel and proximal colon if absorption is to be miximised. Absorption by the transcellular route diminishes in the more distal colon, a fact which has implications for delayed or sustained release formulations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. K. H. Antonin, P. Bieck, M. Scheurlen, M. Jedrychowski, and H. Malchow. Oxprenolol absorption in man after single bolus dosing into two segments of the colon compared with that after oral dosing. Br. J. Clin. Pharm. 19:137S–42S (1985).

    Google Scholar 

  2. C. H. Gleiter, K. H. Antonin, P. Bieck, J. Godbillon, W. Schonleber, and H. Malchow. Colonoscopy in the investigation of drug absorption in healthy volunteers. Gastrointest. Endoscopy 31:71–3 (1985).

    Google Scholar 

  3. C. G. Wilson, M. Bakhshaee, H. E. Stevens, A. C. Perkins, M. Frier, P. E. Blackshaw, and J. S. Binns. Evaluation of a gastro-resistant pulsed release delivery system (Pulsincap) in humans. Drug Del. 4:201–6 (1997).

    Google Scholar 

  4. A. R. Zoest, S. Wanwimolruk, and C. T. Hung. Simple high-performance liquid chromatographic method for the analysis of quinine in human plasma without extraction. J. Liquid Chromatogr. 13:3481–91 (1990).

    Google Scholar 

  5. J. G. Hardy, C. G. Wilson, and E. Wood. Drug delivery to the proximal colon. J. Pharm. Pharmacol. 37:874–77 (1985).

    Google Scholar 

  6. M. Proano, M. Camilleri, S. F. Phillips, M. L. Brown, and G. M. Thomforde. Transit of solids through the human colon: regional quantification in the unprepared bowel. Am. J. Physiol. 258:G856–62 (1990).

    Google Scholar 

  7. I. Torsoli, M. L. Famorino, and V. Crucioli. The relationships between anatomy and motor activity of the colon. Am. J. Dig. Dis. 13:462–67 (1968).

    Google Scholar 

  8. P. S. Kamath, S. F. Phillips, M. K. O'Connor, M. L. Brown, and A. R. Zinsmeister. Colonic capacitance and transit in man: modulation by luminal contents and drugs. Gut 31:443–49 (1990).

    Google Scholar 

  9. L. Barrow, K. P. Steed, R. C. Spiller, P. J. Watts, C. D. Melia, M. C. Davies, and C. G. Wilson. Scintigraphic demonstration of accelerated proximal colonic transit by lactulose and its modification by gelling agents. Gastroenterology 103:1167–73 (1992).

    Google Scholar 

  10. J. Frexinos, L. Bueno, and J. Fioramonti. Diurnal changes in myoelectric spiking activity of the human colon. Gastroenterology 88:1104–10 (1985).

    Google Scholar 

  11. F. Narducci, G. Bassotti, M. Gaburri, and A. Morrelli. Twenty four hour manometric recording of colonic motor activity in healthy man. Gut 28:17–25 (1987).

    Google Scholar 

  12. E. E. Soffer, P. Scalabrini, and D. Wingate. Prolonged ambulant monitoring of human colonic motility. Am. J. Physiol. 257:G601–6 (1989).

    Google Scholar 

  13. G. Bassotti, C. Betti, B. P. Imbimbo, M. A. Pelli, and A. Morelli. Colonic motor response to eating: a manometric investigation in the proximal and distal portions of the viscus in man. Am. J. Gastroenterol. 84:118–22 (1989).

    Google Scholar 

  14. G. Bassotti, C. Betti, C. Fusaro, and A. Morelli. Colonic high-amplitude propagated contractions (mass movements): repeated 24-h manometric studies in healthy volunteers. J. Gastrointest. Mot. 4:187–91 (1992).

    Google Scholar 

  15. R. H. Ghoo, J. G. Moore, E. Greenberg, and N. P. Alazraki. Circadian variation in gastric emptying of meals in humans. Gastroenterol 93:515–18 (1987).

    Google Scholar 

  16. D. Kumar, D. Wingate, and Y. Ruckebusch. Circadian variation in the propagation velocity of the migrating motor complex. Gastroenterology 91:926–30 (1986).

    Google Scholar 

  17. S. Travis and I. Menzies. Intestinal permeability: functional assessment and significance. Clin. Sci. 82:471–88 (1992).

    Google Scholar 

  18. D. G. Maxton, I. Bjarnason, A. P. Reynolds, S. D. Catt, T. J. Peter, and I. S. Menzies. Lactulose, 51Cr-labelled ethylenediaminetetra-acetate, L-rhamnose and polyethyleneglycol 500 as probe markers for assessment in vivo of human intestinal permeability. Clin. Sci. 71:71–80 (1986).

    Google Scholar 

  19. I. Bjarnason, D. Maxton, A. P. Reynolds, S. Catt, T. J. Peters, and I. S. Menzies. Comparison of four markers of intestinal permeability in control subjects and patients with coeliac disease. Scand. J. Gastroenterol. 29:630–39 (1994).

    Google Scholar 

  20. L. A. Salako and A. Sowunmi. Disposition of quinine in plasma, red blood cells and saliva after oral and intravenous administeration to healthy adult Africans. Eur. J. Clin. Pharmacol. 42:171–74 (1992).

    Google Scholar 

  21. G. Paintaud, G. Alvan, and O. Ericsson. The reproducibility of quinine bioavailability. Br. J. Clin. Pharm. 35:305–7 (1993).

    Google Scholar 

  22. R. D. Pullan, G. A. O. Thomas, M. Rhodes, R. G. Newcombe, G. T. Williams, A. Allen, and J. Rhodes. Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut 35:353–59 (1994).

    Google Scholar 

  23. J. M. Hebden, A. C. Perkins, P. J. Gilchrist, P. E. Blackshaw, C. G. Wilson, and R. C. Spiller. A dual radionuclide study for the investigation of colonic drug delivery and absorption. Nucl. Med. Commun. 16:232 (1995).

    Google Scholar 

  24. I. Bjarnason, T. J. Peter, and N. Veall. A persistent defect in intestinal permeability in coeliac disease demonstrated by a 51Cr-labelled EDTA absorption test. Lancet i:323–25 (1983).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hebden, J.M., Wilson, C.G., Spiller, R.C. et al. Regional Differences in Quinine Absorption from the Undisturbed Human Colon Assessed Using a Timed Release Delivery System. Pharm Res 16, 1087–1092 (1999). https://doi.org/10.1023/A:1018948102778

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018948102778

Navigation